← Back to all trials
Recruiting
NCT02015013
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Conditions: Idiopathic CD4-Positive, T-Lymphocytopenia
Sex: All
Ages: 18 Years – 65 Years
Healthy volunteers: Yes
Phase: PHASE2
Enrollment: 40
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Location: National Institutes of Health Clinical Center Bethesda Maryland
Summary
Idiopathic CD4 lymphocytopenia (ICL) is a rare syndrome defined by consistently low CD4 T cell counts (\
Eligibility Criteria
* INCLUSION CRITERIA
ICL patients:
1. Documented history of idiopathic CD4 lymphocytopenia as defined by CD4 T cell count \
Source: ClinicalTrials.gov (NCT02015013). StuddyBuddy aggregates publicly available trial information.
